U.S. Stock Market Midday Update

Hims & Hers Health fell 9.07%. Based on recent key news:

1. On August 24, Kessler Topaz Meltzer & Check law firm announced an investigation into Hims & Hers Health, accusing it of deceptive privacy practices and sharing patient data with advertisers. This news caused the stock price to drop over 14% at one point during the trading session. Source: Zhitong Finance

2. On August 22, Visa placed Hims & Hers Health on a watchlist due to a surge in customer complaints about its weight loss subscription service, requiring its credit card dispute rate to fall below 1.5% of transaction volume. This move increased pressure on its business model. Source: Bloomberg

3. On August 22, the FTC filed a lawsuit against Hims & Hers Health, accusing it of making subscriptions difficult to cancel and imposing unnecessary charges on customers. This lawsuit heightened market concerns about its business model. Source: Bloomberg. The telemedicine industry is facing regulatory pressure, with significant capital outflows.

Stocks with High Trading Volume in the Industry

CVS rose 0.04%, with active trading. Based on recent key news:

1. On August 23, CVS faced operational challenges but made significant progress in healthcare benefits. Analysts are optimistic about its retail and insurance businesses, expecting a 22% growth potential in stock price. Source: MarketBeat

2. On August 22, CVS Health was rated as a moderate buy, but top analysts believe there are five stocks with better investment value. Source: MarketBeat

3. On August 22, Optum's digital product report showed a 96% first-pass rate, with Q2 revenue reaching $112 billion, and CVS's management is facing challenges brought by AI technology. Source: 24/7 Wall St.

Guardant Health fell 3.20%. Based on recent key news:

1. On August 24, a court ordered Guardant Health to submit quarterly financial reports and pay a 6% ongoing royalty on disputed products until the patent officially expires in March 2033. This ruling upheld the validity of two disputed patents, leading to a drop in stock price.

2. On August 24, TwinStrand stated that the products and services involved in the ruling accounted for about 90% of Guardant's revenue during the infringement period. The maintenance of this ruling has a significant impact on Guardant's financial condition, further depressing the stock price.

3. On August 24, analyst ratings showed that although Guardant Health is currently rated as "moderate buy," top analysts believe there are five stocks that are more worthy of purchase, which undermines market confidence in Guardant. The biotechnology industry is facing patent litigation risks Hinge Health rose 1.68%. Based on recent key news:

4. On August 21, Hinge Health raised its outlook in the latest earnings call, driven by strong operational momentum and improved cash flow, which boosted the stock price. Source: SEC filings

5. On August 19, Hinge Health director Elliott Robinson indirectly sold 26,226 shares of common stock at a price of $90.05 per share, which may exert short-term pressure on the stock price. Source: EDGAR system

6. Recently, analyst Spark gave Hinge Health an "outperform" rating, mainly due to its low debt and strong operational performance, further boosting market confidence. Source: TipRanks Digital Health industry performs strongly, with significant capital inflows.

Stocks ranked among the top in industry market capitalization

Cigna Insurance rose 0.27%. Based on recent key news:

1. On August 24, analysts rated Cigna Insurance as a moderate buy but noted that five other stocks are more attractive. This rating may have affected investor confidence in Cigna Insurance, leading to stock price fluctuations.

2. On August 22, Optum's digital authorization product report showed a first-time approval rate of 96%, with second-quarter revenue of $112 billion. Although this is not directly related to Cigna Insurance, technological advancements and revenue growth in the industry may have an indirect impact on Cigna Insurance's market performance.

3. Recently, there has been widespread discussion in the market about the application of artificial intelligence in the healthcare industry, particularly regarding its impact on management. As an important company in the industry, Cigna Insurance may be influenced by investor attention and expectations regarding the application of AI technology. Technological advancements in the healthcare industry have sparked market interest